Children presented with clinical manifestation of allergic rhinitis and asthma due to house dust mites Rhinitis, Asthma, Allergy and Immunology, Child, Immunotherapy
Conditions
Interventions
Subcutaneous house dust mite (HDM) immunotherapy (Teaching Industry Allergen by Dr Soetomo General Academic Hospital and Universitas Airlangga, Surabaya, Indonesia) will be administered to participant
Subcutaneous HDM Immunotherapy,Subcutaneous HDM Immunotherapy
Sponsors
Universitas Airlangga
Eligibility
Sex/Gender
All
Age
1 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Children diagnosed with rhinitis allergies according to a house dust mite-specific skin prick test. 2. Children with or without asthma. 3. Children must be under <18 years of age. 4. The guardian must be acceptable.
Exclusion criteria
Exclusion criteria: 1. Children who have an onset of acute asthma. 2. Children who have a history of anaphylaxis. 3. Children with other ongoing diseases, especially infectious diseases, skin disease, metastases, or immunodeficiency, were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laboratory 14 weeks ELISA | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom Medical Score 14 weeks Questionnaire | — |
Countries
Indonesia
Contacts
Public ContactAzwin Putera
Universitas Airlangga
Outcome results
None listed